Zai Lab (ZLAB) Change in Receivables (2020 - 2026)
Zai Lab (ZLAB) posted Change in Receivables of -$53.3 million for Q1 2026, down 370.97% sequentially from $19.7 million in Q4 2025, and down 509.68% YoY from $13.0 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Change in Receivables (2020 - 2026) Analysis & Trends
Zai Lab has reported Change in Receivables for 7 years, with the latest figure at -$53.3 million in Q1 2026.
- Quarterly Change in Receivables fell 509.68% year-over-year to -$53.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.6 million (down 251.38% YoY) and the FY2025 annual result came in at $18.9 million, down 29.82% from the prior year.
- Change in Receivables slipped to -$53.3 million in Q1 2026 per ZLAB's latest filing, from $19.7 million in the prior quarter.
- Over five years, Change in Receivables peaked at $36.7 million in Q4 2024 and troughed at -$53.3 million in Q1 2026.
- A 5-year average of $491117.6 and a median of $2.9 million in 2023 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 194.78% in 2023, then slumped 757.91% in 2025.
- Over 5 years, Change in Receivables stood at $12.2 million in 2022, then soared by 41.67% to $17.2 million in 2023, then surged by 113.09% to $36.7 million in 2024, then sank by 46.42% to $19.7 million in 2025, then sank by 370.97% to -$53.3 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$53.3 million, $19.7 million, and -$3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -53.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 117.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 14.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.24 Mn |
| Mar 31, 2026 | -53.27 Mn |
| Dec 31, 2025 | 19.66 Mn |
| Sep 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Mar 31, 2025 | -8.74 Mn |
| Dec 31, 2024 | 36.69 Mn |
| Sep 30, 2024 | -20.55 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Sep 30, 2023 | -6.04 Mn |
| Jun 30, 2023 | 6.01 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 12.15 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | -6.34 Mn |
| Mar 31, 2022 | -14.08 Mn |
| Dec 31, 2021 | 26.46 Mn |
| Sep 30, 2021 | 2.99 Mn |